Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Parenti

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Viruses|October 26, 2021
Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSVAndrea Vannini, Federico Parenti, Daniela Bressanin, et al.
Frontiers in Molecular Biosciences|July 10, 2024
Corrigendum: Innovative retargeted oncolytic herpesvirus against nectin4-positive cancersAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Frontiers in Molecular Biosciences|May 30, 2023
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancersAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
NPJ 2D Materials and Applications|April 26, 2024
Biodegradable albumen dielectrics for high-mobility MoS<sub>2</sub> phototransistorsThomas Pucher, Pablo Bastante, Federico Parenti, et al.
Cancers|March 28, 2024
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer EfficacyAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Journal for Immunotherapy of Cancer|July 23, 2025
Gnostic and agnostic immunotherapy by tropism-retargeted herpes simplex virus without direct tumor treatmentAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Viruses|September 28, 2021
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSVTatiana Gianni, Valerio Leoni, Mara Sanapo, et al.
Veterinary Sciences|August 26, 2021
Pathological Findings of Canine Idiopathic Pericarditis and Pericardial Mesotheliomas: Correlation with Clinical and Survival DataMichela Levi, Federico Parenti, Luisa Vera Muscatello, et al.
Cancers|August 26, 2023
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune MiceAndrea Vannini, Federico Parenti, Catia Barboni, et al.
Animals : an Open Access Journal From MDPI|April 3, 2021
High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and OutcomeMichela Levi, Luisa Vera Muscatello, Barbara Brunetti, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Viruses|October 26, 2021
Towards a Precision Medicine Approach and In Situ Vaccination against Prostate Cancer by PSMA-Retargeted oHSVAndrea Vannini, Federico Parenti, Daniela Bressanin, et al.
Frontiers in Molecular Biosciences|July 10, 2024
Corrigendum: Innovative retargeted oncolytic herpesvirus against nectin4-positive cancersAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Frontiers in Molecular Biosciences|May 30, 2023
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancersAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
NPJ 2D Materials and Applications|April 26, 2024
Biodegradable albumen dielectrics for high-mobility MoS<sub>2</sub> phototransistorsThomas Pucher, Pablo Bastante, Federico Parenti, et al.
Cancers|March 28, 2024
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer EfficacyAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Journal for Immunotherapy of Cancer|July 23, 2025
Gnostic and agnostic immunotherapy by tropism-retargeted herpes simplex virus without direct tumor treatmentAndrea Vannini, Federico Parenti, Cristina Forghieri, et al.
Viruses|September 28, 2021
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSVTatiana Gianni, Valerio Leoni, Mara Sanapo, et al.
Veterinary Sciences|August 26, 2021
Pathological Findings of Canine Idiopathic Pericarditis and Pericardial Mesotheliomas: Correlation with Clinical and Survival DataMichela Levi, Federico Parenti, Luisa Vera Muscatello, et al.
Cancers|August 26, 2023
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune MiceAndrea Vannini, Federico Parenti, Catia Barboni, et al.
Animals : an Open Access Journal From MDPI|April 3, 2021
High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and OutcomeMichela Levi, Luisa Vera Muscatello, Barbara Brunetti, et al.
Pageof 2